IceCure Medical (NASDAQ:ICCM) and CVS Health (NYSE:CVS) Head to Head Analysis

IceCure Medical (NASDAQ:ICCMGet Free Report) and CVS Health (NYSE:CVSGet Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Institutional & Insider Ownership

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 1.2% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings for IceCure Medical and CVS Health, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical 1 1 2 0 2.25
CVS Health 0 4 20 2 2.92

IceCure Medical currently has a consensus price target of $2.64, indicating a potential upside of 311.72%. CVS Health has a consensus price target of $93.71, indicating a potential upside of 17.43%. Given IceCure Medical’s higher possible upside, research analysts plainly believe IceCure Medical is more favorable than CVS Health.

Valuation and Earnings

This table compares IceCure Medical and CVS Health”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IceCure Medical $3.29 million 13.36 -$15.32 million ($0.26) -2.46
CVS Health $372.81 billion 0.27 $4.61 billion $0.38 210.00

CVS Health has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

IceCure Medical has a beta of 0.28, suggesting that its stock price is 72% less volatile than the S&P 500. Comparatively, CVS Health has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500.

Profitability

This table compares IceCure Medical and CVS Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
IceCure Medical -513.95% -243.68% -123.94%
CVS Health 0.12% 11.45% 3.40%

Summary

CVS Health beats IceCure Medical on 12 of the 15 factors compared between the two stocks.

About IceCure Medical

(Get Free Report)

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

About CVS Health

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.